 | Up a level |
Wagenhäuser, Isabell; Reusch, Julia; Gabel, Alexander; Mees, Juliane; Nyawale, Helmut; Frey, Anna; Lâm, Thiên-Trí; Schubert-Unkmeir, Alexandra; Dölken, Lars; Kurzai, Oliver; Frantz, Stefan; Petri, Nils; Krone, Manuel; Krone, Lukas B (2024). The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations. Journal of sleep research, 33(3), e13929. Wiley 10.1111/jsr.13929
Vij, Vivian; Cruz-González, Ignacio; Galea, Roberto; Piayda, Kerstin; Nelles, Dominik; Vogt, Lara; Gloekler, Steffen; Fürholz, Monika; Meier, Bernhard; Räber, Lorenz; O'Hara, Gilles; Arzamendi, Dabit; Agudelo, Victor; Asmarats, Lluis; Freixa, Xavier; Flores-Umanzor, Eduardo; De Backer, Ole; Sondergaard, Lars; Nombela-Franco, Luis; McInerney, Angela; ... (2023). Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry. Clinical research in cardiology, 112(12), pp. 1790-1799. Springer-Verlag 10.1007/s00392-023-02237-w
Wagenhäuser, Isabell; Mees, Juliane; Reusch, Julia; Lâm, Thiên-Trí; Schubert-Unkmeir, Alexandra; Krone, Lukas B; Frey, Anna; Kurzai, Oliver; Frantz, Stefan; Dölken, Lars; Liese, Johannes; Gabel, Alexander; Petri, Nils; Krone, Manuel (2023). Determinants of Influenza A Infection Rate in Post-COVID-19 Era. Journal of infection, 87(4), pp. 361-364. Elsevier 10.1016/j.jinf.2023.08.003
Wagenhäuser, Isabell; Reusch, Julia; Gabel, Alexander; Krone, Lukas B; Kurzai, Oliver; Petri, Nils; Krone, Manuel (2023). Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster. Clinical microbiology and infection, 29(4), pp. 554-556. Elsevier 10.1016/j.cmi.2023.01.008
Wagenhäuser, Isabell; Reusch, Julia; Gabel, Alexander; Höhn, Anna; Lâm, Thiên-Trí; Almanzar, Giovanni; Prelog, Martina; Krone, Lukas B; Frey, Anna; Schubert-Unkmeir, Alexandra; Dölken, Lars; Frantz, Stefan; Kurzai, Oliver; Vogel, Ulrich; Petri, Nils; Krone, Manuel (2023). Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination. The European respiratory journal, 61(1) European Respiratory Society 10.1183/13993003.01390-2022
